MacroGenics
Latest round
- Series D
Last raised
- Jan 2013
Total raised
- $117M
Investors
- 25
About MacroGenics
MacroGenics, Inc.Founded in 2000 and headquartered in Rockville, US, MacroGenics specializes in innovative cancer therapies. The company has undergone strategic pivots to enhance its focus on oncology therapeutics. Its CEO, Scott Koenig, has a strong background in the biopharmaceutical industry.MacroGenics develops monoclonal antibody-based therapeutics for cancer treatment, including Lorigerlimab, MGC026, MGC028, and MGD024. These products target specific mechanisms within the immune system to improve anti-tumor responses.04 mn.MacroGenics plans to further develop its innovative therapeutics pipeline, with ongoing research into new products targeting specific cancer types.
Who invested in MacroGenics
25 investors across 7 rounds
See all investors in MacroGenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 14, 2013
Amount
Undisclosed
Investors
Series D
Sep 25, 2008
Amount
$25M
Investors
Series D
Jul 29, 2008
Amount
$13M
Investors
Series C
May 17, 2006
Amount
$35M
Investors
Series B
Oct 15, 2004
Amount
$31M
Investors
Series A
Sep 25, 2001
Amount
$9.5M
Investors
Series A
Jun 1, 2001
Amount
$4M
Investors
Questions about MacroGenics
Who invested in MacroGenics?
MacroGenics has 25 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MacroGenics raised?
MacroGenics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did MacroGenics last raise money?
MacroGenics's most recent round on record is a Series D, in Jan 2013.
What does MacroGenics do?
MacroGenics is a biotechnology company.
Where is MacroGenics headquartered?
MacroGenics is headquartered in Rockville, US.
Which VCs invest in companies like MacroGenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MacroGenics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like MacroGenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.